Metalmark Capital, a leading private equity firm investing in industrials, healthcare, financial services, energy and other natural resources, announced today that Fazle Husain will join the firm as a Managing Director. Mr. Husain is currently a Managing Director of Morgan Stanley.
Over an eighteen year career at Morgan Stanley, Mr. Husain managed a portfolio that included over 40 healthcare companies. At Metalmark, he will apply his expertise to extend the firm’s reach in the healthcare sector.
“Metalmark Capital has a successful track record investing in the healthcare sector. The addition of Fazle to our team will enable us to build on our experience and enhance our ability to capitalize on the significant opportunities available in the healthcare industry,” said Howard Hoffen, Chairman and Chief Executive Officer of Metalmark Capital.
Mr. Husain has served on more than a dozen boards in recent years, including Allscripts Healthcare, Cambridge Heart, Cross Country, The Medicines Company, SouthernCare Hospice and Suros Surgical. He has also led equity investments in several leading healthcare and life science companies, including Quintiles Transnational, Cytyc, Enterprise Systems and Cardiac Pathways.
Husain received his bachelor’s degree in Chemical Engineering from Brown University and his M.B.A. from Harvard Business School.
About Metalmark Capital LLC
Metalmark Capital is a leading private equity firm established by the principals of Morgan Stanley Capital Partners (MSCP) to manage the Metalmark Capital and MSCP funds. Since 1986, the Metalmark Capital and MSCP funds have invested $7 billion of equity capital in over 100 companies in a broad range of industries, including their focus sectors of industrials, healthcare, financial services and natural resources. For more information on Metalmark Capital, please visit metalmarkcapital.com.
Comments